---
title: "Usatine & Erickson Media LLC — Publisher Overview"
type: publisher
publisher: "Usatine & Erickson Media LLC"
publisher_slug: "usatine-erickson-media-llc"
canonical_url: "https://marlvel.ai/publishers/usatine-erickson-media-llc"
last_updated: 2026-05-05T14:08:24.414Z
source: Marlvel.ai
license: CC-BY-NC-4.0
citation: "Marlvel.ai — Usatine & Erickson Media LLC Publisher Overview"
---
## ⚠ Content Warning

This publisher's portfolio includes apps classified as sensitive (health, adult). Information is aggregated from public sources for informational purposes only. This overview touches health-related apps. It is not medical advice.

---

# Usatine & Erickson Media LLC — Publisher Overview

> Providing medical professionals with specialized clinical reference and board review tools. Supporting diagnostic accuracy and exam preparation.

- **Publisher:** Usatine & Erickson Media LLC
- **Website:** [https://usatinemedia.com](https://usatinemedia.com)
- **Overview generated:** 2026-05-05
- **License:** CC-BY-NC 4.0

## Executive summary

Usatine & Erickson Media operates as a specialized publisher of medical reference content, leveraging established clinical literature to provide digital study aids and diagnostic support. Their positioning relies on the conversion of high-trust, peer-reviewed medical texts into mobile-first formats, effectively serving as a digital extension of traditional medical education. The primary strategic tension lies in the maintenance of a large, legacy-heavy portfolio where the majority of titles remain static, suggesting a focus on long-tail utility rather than aggressive feature iteration. Their moat is built on the integration of recognized medical titles and clinical algorithms, which provides inherent credibility within the medical community.

## Publisher DNA

- **Primary focus:** Medical reference and board review applications
- **Scale:** studio
- **Target audience:** Medical residents, physicians, and healthcare professionals preparing for board certification or seeking rapid clinical diagnostic support.

## Portfolio momentum

- **Velocity:** maintenance
- **Active apps:** 5
- **Abandoned apps:** 42
- **Last major release:** 62 days ago

With 42 of 50 apps classified as abandoned and only 3 releases in the last 6 months, the publisher maintains a legacy-focused, low-velocity development cycle.

## Aggregated portfolio metrics

- **Total reviews (all apps):** 447
- **Weighted rating:** 4.04 / 5
- **Apps in portfolio:** 50

## Category breakdown

| Category | Apps | Share |
| :--- | :--- | :--- |
| Medical | 50 | 100% |

## Top apps

- **Poisoning and Drug Overdose 8E** — Flagship reference tool with 390 reviews.
- **Pediatric Dermatology DDx Deck** — Visual diagnostic aid with 36 reviews.
- **Dermoscopy Two Step Algorithm** — Specialized diagnostic tool with 10 reviews.
- **The NeuroICU Board Review** — High-rated board prep tool with 5.0 rating.
- **Pulmonary Disease Board Review** — Specialty-focused board review app.

## Signature patterns

- Exclusive focus on the Medical category
- Content-heavy apps featuring clinical protocols, diagnostic algorithms, and board review question banks
- Mixed monetization strategy utilizing both free reference tools and paid study materials
- Heavy reliance on established medical textbook content and visual atlases

## Bottom line

Usatine & Erickson Media occupies a stable niche by digitizing authoritative medical content for professional use. Their value proposition is tied to the clinical utility of their source material rather than mobile-native engagement mechanics.

---
© 2026 Marlvel.ai | [Publisher apps index](https://marlvel.ai/api/llm/publishers/usatine-erickson-media-llc) | [Methodology](https://marlvel.ai/api/llm/methodology)
Data licensed under CC-BY-NC 4.0.

---
© 2026 Marlvel.ai | [Full publisher profile](https://marlvel.ai/publishers/usatine-erickson-media-llc) | [Publisher apps index](https://marlvel.ai/api/llm/publishers/usatine-erickson-media-llc) | [Methodology](https://marlvel.ai/api/llm/methodology)
Data licensed under CC-BY-NC 4.0.